Rob Dale
Rob runs technical and SEO strategy at Business of Cannabis and has a Master’s in Clinical Exercise Physiology. He blends search know-how with a solid grasp of clinical methods to spot what actually matters in new studies and regulations. Day to day, he helps shape evidence-based explainers and features, translating data into clear, useful insights for industry pros.
Rob Dale · page 2
- Markets & Stocks
Cannabis Stocks Today — Monday 8 June 2026: Trulieve at $11.74 as MSOS Extends to $5.66 in Broad Intraday Advance
Cannabis enters the new week with a broadly positive bias across the tracked universe.
- Cannabis Daily News
Cannabis News Today — Monday 8 June 2026: First US Cannabis Stock Reaches Major Exchange as Rescheduling Faces Legal Pressure
The week opens with a landmark moment for cannabis capital markets as Trulieve prepares to become the first US cannabis company to list on a major American exchange.
- Markets & Stocks
Cannabis Stocks Today — Friday 5 June 2026: Trulieve Trades at $9.99 as MSOS Holds at $5.10 Pre-Market
Cannabis stocks enter Friday’s pre-market session broadly positive.
- Cannabis Daily News
Cannabis News Today — Friday 5 June 2026: Alabama opens its medical market as rescheduling opponents press their case
Thursday marked the end of a five-year wait for Alabama: its first licensed medical cannabis dispensary began trading, a milestone that arrived alongside intensifying opposition to the federal rescheduling order.
- Cannabis Daily News
Cannabis News Today — Thursday 4 June 2026: Legislators Widen Medical Cannabis Access as New Research Backs Therapeutic Potential
A run of legislative action across the United States and Australia is broadening medical cannabis access, while a new peer-reviewed study adds clinical weight to one of the plant’s therapeutic applications.
- Markets & Stocks
Cannabis Stocks Today — Wednesday 4 June 2026: MSOS Falls to .74 as US Operators Extend Losses
The cannabis sector is entering Wednesday’s pre-market session in broadly negative territory, with the US benchmark fund MSOS now sitting at $4.74, a retreat from $5.05 at Tuesday’s close.
- M&A Activity
AYR Wellness Completes Asset Handover as MSO Sector’s Largest Collapse Draws to a Close
AYR Wellness (CSE: AYR.A) has finalised the transfer of its Florida, New Jersey and Nevada cannabis operations to Arboretum Bidco LLC, bringing the state-by-state handover of assets to a close in what amounts to the largest restructuring in multi-state operator (MSO) history.
- Cannabis Daily News
Cannabis News Today — Tuesday 3 June 2026: Congress blocks hemp relief as Germany’s drug chief breaks with party line
Tuesday’s cannabis headlines ranged from Capitol Hill to Berlin.
- Markets & Stocks
Cannabis Stocks Today — Monday 1 June 2026: MSOS Climbs to $5.01 as IM Cannabis and iPower Lead NASDAQ Gains
Cannabis equities begin June in mixed fashion, with the sector’s exchange-listed names showing a slight positive bias while OTC-traded US multi-state operators carry the weight of last Friday’s declines into Monday’s session.
- Cannabis Daily News
Cannabis News Today — Sunday 1 June 2026: Rescheduling under legal strain as Tennessee confirms THCA deadline
The legal soundness of the United States’ cannabis rescheduling process came under renewed scrutiny on Sunday as fresh analysis argued that the post-Chevron regulatory landscape may expose the DEA’s scheduling procedures to constitutional challenge.
- Markets & Stocks
Cannabis Stocks Today — Wednesday 20 May 2026: iPower Plunges to $0.54 as Canadian LPs Hold Firm in Early Trade
Cannabis equities open Wednesday’s US session with modest positive breadth among exchange-listed names, though the sector’s headline data point is a sharp intraday plunge in iPower (IPW), the hydroponic supply retailer with direct exposure to the cannabis cultivation market.
- Cannabis Daily News
Cannabis News Today — Wednesday 20 May 2026: Virginia Governor Kills Sales Bill as DOT Holds Line on Transport Drug Testing
Wednesday’s dominant story is Virginia Governor Abigail Spanberger’s decision to veto legislation that would have created the state’s first licensed cannabis retail market, leaving personal possession legal and the unregulated market unaddressed for at least another year.
